A review on the COVID-19, its history, diagnostic approaches, role of herbs and current world scenario


  • Singh Devendra
  • Agarwal Vishnu




Lianhua-Qingwen, COVID-19, herbal plant, SARS-CoV-2


COVID- 19, a novel coronavirus disease caused by SARS-CoV-2 (severe acute respiratory syndrome caused by coronavirus-2) transmitted from person to person, is now declared as a pandemic worldwide by WHO. SARS-CoV-2 belongs to the family of Coronaviridae. Covid-19 (Coronavirus disease 2019) is an infectious disease with clinical symptoms like fever, sore throat, sneezing, shortness of breath, fatigue, cough, diarrhoea, chills, and respiratory symptoms that has now entered into the new dangerous phase. This virus can easily extend and can cause severe illness to the global village. Till 7Nov 2020, the total number of confirmed COVID-19 cases was 48534508, and the death number is 1231017, affecting, directly and indirectly, more than 215 territories worldwide. Hence an effective international strategy is required to control and prevent this disaster. To combat the coronavirus-2 different approaches have been initiated in scientific concern, but focussed attention should be given to the medical value of herbal plant extract to prevent these endemic type diseases. Hence, this review describes the symptoms and the role of herbal plants in treating the COVID-19.


Author Biographies

Singh Devendra

Department of Biotechnology, Motilal Nehru National Institute of Technology, Allahabad, 211004, Uttar Pradesh, India

Agarwal Vishnu

Department of Biotechnology, Motilal Nehru National Institute of Technology, Allahabad, 211004, Uttar Pradesh, India


Qiao, J. What are the risks of COVID-19 infection in pregnant women?Lancet. 2020;395:760-762.

Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., et al.,Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet. Respire. Med. 2020;8:420-422.

Wan, Y., Shang, J., Graham, R., Baric, R. S., Li, F. Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS. Journal of Virology. 2020;94:e00127-20.

Balachandar, V., Mahalaxmi, I., Kaavya, J., Vivekanandhan, G., Ajithkumar, S., Arul, N.,et al.,COVID-19: emerging protective measures. European Review for Medical and Pharmacological Sciences.2020;24:3422-3425.

Jiang, S., Shi, Z., Shu, Y., Song, J., Gao, G. F., Tan, W., et al.,A distinct name is needed for the new coronavirus. Lancet. 2020;395(10228):949.

Weiss, S. R., Navas-Martin, S. Coronavirus pathogenesis and the emergingpathogensevere acute respiratory syndrome coronavirus. Microbiology and Molecular Biology Reviews. 2005;69:635-664.

Neuman, B. W., Adair, B. D., Yoshioka, C., Quispe, J. D., Orca, G., Kuhn, P., et al.,Supramolecular architecture of severe acute respiratory syndrome coronavirus revealed by electron cryomicroscopy. Journal of Virology. 2006;80:7918-7928.

Chan, J. F. W., Kok, K. H., Zhu, Z., Chu, H., To, K. K. W., Yuan, S., et al.,Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerging Microbes and Infections. 2020;9:221-236.

Guarner, J. Three emerging coronaviruses in two decades. American Journal of Clinical Pathology. 2020;153:420-421.

Forster, P., Forster, L., Renfrew, C., Forster, M. Phylogenetic network analysis of SARS-CoV-2 genomes. Proceedings of the National Academy of Sciences of the United States of America. 2020;117:9241-9243.

Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., et al.,Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497-506.

Song, Z., Xu, Y., Bao, L., Zhang, L., Yu, P., Qu, Y., et al.,From SARS to MERS, thrusting coronaviruses into the spotlight. Viruses. 2019;11:59.

Yin, Y., Wunderink, R. G. MERS, SARS and other coronaviruses as causes of pneumonia. Respirology. 2018;23:130-137.

Bosch, B. J., van der Zee, R., de Haan, C. A., Rottier, P. J.The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. Journal of Virology. 2003;77:8801-8811.

Siu, Y. L., Teoh, K. T., Lo, J., Chan, C. M., Kien, F., Escriou, N., et al.,Structural proteins of the severe acute respiratory syndrome coronavirusarerequired for ef?cientassembly, traf?cking, and release of virus-likeparticles. Journal of Virology. 2008;82:11318-11330.

Menni, C., Valdes, A., Freydin, M. B., Ganesh, S., Moustafa, J. E., Visconti, A., et al.,Loss of smell and taste in combination with other symptoms is a strong predictor of COVID-19 infection. MedRxiv. 2020.

Li, Z., Yi, Y., Luo, X., Xiong, N., Liu, Y., Li, S., et al.,Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis. Journal of Medical Virology. 2020;92(9):1518–1524.

Zhang, W., Du, R. H., Li, B., Zheng, X. S., Yang, X. L., Hu, B., et al.,Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerging Microbes and Infections. 2020;9:386-389.

Carver, C., Jones, N. Comparative accuracy of oropharyngeal and nasopharyngeal swabs for diagnosis of COVID-19. Oxford COVID-19 evidence service team centre for evidence based medicine. 2020.

Sheridan, C. Fast, portable tests come online to curb coronavirus pandemic. Nature Biotechnology. 2020;38:509-511.

Yao, X., Ye, F., Zhang, M., Cui, C., Huang, B., Niu, P., et al.,In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2). Clinical Infectious Diseases. 2020;71:732-739.

Gao, J., Tian, Z., Yang, X. Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. BioScience Trends. 2020;14:72-73.

Wagstaff, K. M., Sivakumaran, H., Heaton, S. M., Harrich, D., Jans, D. A.Ivermectin is a specific inhibitor of importin ?/?-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus. Biochemical Journal. 2012;443:851-856.

Furuta, Y., Takahashi, K., Shiraki, K., Sakamoto, K., Smee, D. F., Barnard, D. L., et al.,T-705 (favipiravir) and related compounds: novel broad- spectrum inhibitors of RNA viral infections. Antiviral Research. 2009;82:95-102.

Luo, H., Tang, Q. L., Shang, Y. X., Liang, S. B., Yang, M., Robinson, N., et al.,Can Chinese medicine be used for prevention of Corona Virus Disease 2019 (COVID-19)?A review of historical classics, research evidence and current prevention programs. Chinese Journal of Integrative Medicine. 2020;26:243-250.

Hoever, G., Baltina, L., Michaelis, M., Kondratenko, R., Baltina, L., Tolstikov, G. A., et al.,Antiviral activity of glycyrrhizicacidderivatives against SARS? coronavirus. Journal of Medicinal Chemistry. 2005;48:1256-1259.

Chen, F., Chan, K. H., Jiang, Y., Kao, R. Y. T., Lu, H. T., Fan, K. W., et al.,In vitro susceptibility of 10 clinical isolates of SARScoronavirus to selected anti-viral compounds. Journal of Clinical Virology. 2004;31:69-75.

Ding, Y., Zeng, L., Li, R., Chen, Q., Zhou, B., Chen, Q.,et al.,The Chinese prescription lianhuaqingwen capsule exerts anti-influenza activity through the inhibition of viral propagation and impacts immune function. BMC Complementary and Alternative Medicine 2017;17:130.

Gao, D., Niu, M., Wei, S. Z., Zhang, C. E., Zhou, Y. F., Yang, Z. W.,et al.,Identification of a pharmacologicalbiomarker for the bioassay-basedqualitycontrol of a thirteen-componentTCMformula (LianhuaQingwen) used in treatinginfluenza A virus (H1N1) infection. Frontiers in Pharmacology. 2020;11:746.

Yang,Y., Islam,M. S., Wang,J., Li,Y., Chen,X. Traditional Chinese medicine in the treatment of patientsinfected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective. International Journal of Biological Sciences. 2020;16:1708-1717.




How to Cite

Devendra S, Vishnu A. A review on the COVID-19, its history, diagnostic approaches, role of herbs and current world scenario. Biomedicine [Internet]. 2021Sep.7 [cited 2021Sep.22];41(2):328-32. Available from: https://biomedicineonline.org/index.php/home/article/view/1032